An investigational EGFR x HER3 antibody-drug conjugate demonstrated promising efficacy with a tolerable safety profile in patients with previously treated EGFR-mutated non-small cell lung cancer (NSCLC), supporting selection ...
2 hours ago
0
0
Patients with resectable stage II–IIIB non-small cell lung cancer (NSCLC) treated with perioperative atezolizumab plus platinum-based chemotherapy experienced a median event-free survival of 62.8 months compared with 34.9 ...
2 hours ago
0
0
Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or progression-free survival in patients with metastatic non-small cell lung cancer (NSCLC), ...
2 hours ago
0
0
The investigational combination of pumitamig and elfetabart drozuntecan (elfe-D) demonstrated a manageable safety profile and encouraging early antitumor activity in patients with small cell lung cancer (SCLC), according ...
2 hours ago
0
0
Extended-interval dosing regimens of tarlatamab demonstrated efficacy, safety and pharmacokinetic profiles generally consistent with the established every-two-week regimen in patients with previously treated small cell lung ...
2 hours ago
0
0
Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage small cell lung cancer (ES-SCLC), according to findings from ...
3 hours ago
0
0
In children with difficult-to-diagnose epilepsy, PET/MRI can pinpoint areas of the brain responsible for seizures, even when MRI scans are negative or inconclusive. A new study of a large pediatric cohort, including children ...
8 hours ago
0
1
Early, consistently managed treatment can have a decisive impact on the course of rheumatoid arthritis and prevent permanent joint damage. An international review led by Josef S. Smolen of the Medical University of Vienna ...
9 hours ago
0
2
Diphtheria toxoid and acellular pertussis (Tdap) and quadrivalent meningococcal conjugate (MenACWY) vaccination coverage for adolescents remained around 90% in 2025, and human papillomavirus (HPV) vaccination did not increase ...
10 hours ago
0
2
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have identified a promising antiviral compound that can inhibit a range of enteroviruses, including Enterovirus D68 (EV-D68), ...
11 hours ago
0
4
